Child Hair Loss Research

A new research study in Miami may offer access to an investigational treatment at no cost.

Check if your child qualifies
IRB approved
No Cost to Participate

“You’ve spent time consulting dermatologists, trying treatments, and searching for answers about your skin concerns, especially during restless nights. If this resonates with you, know that you’re not alone in your journey”.


Alopecia Areata affects thousands of adolescents across the country, and for many families, the path from diagnosis to finding real, meaningful support can feel uncertain and exhausting. The options available to teens have historically been limited — treatments designed for adults, little research focused specifically on adolescents, and no clear answers about what comes next.

/

What does your family receive?

A specialized program

Access to board-certified pediatric specialist in skin conditions

Keep on Track

Close care and monitoring from specialist throughout the study

Reimbursements

Compensation for your time and reasonable travel expenses.

Check Eligibility

Unlock answers for their unique skin

This research evaluates how well deuruxolitinib supports hair regrowth, how safe it is, and how it may affect eyebrows, eyelashes, and overall quality of life in adolescents with severe alopecia areata.

The study comprises a 24-week double-blind treatment phase, followed by a 52-week open-label extension, during which all participants receive the active medication. Subsequently, a 4-week follow-up period is conducted. The medication is administered orally twice daily.

Your privacy is important to us. Any information you provide through this website or during the eligibility screening process will be kept strictly confidential and used only for the purpose of evaluating potential participation in this research study.

Your child’s personal and medical information will be handled in accordance with applicable privacy laws and research regulations. Submitting your information does not obligate you to participate in the study.

Does your child meet the basic criteria?

Children may be eligible if they meet the following general conditions. A study team member will review your child’s full history during the screening process.

Basic eligibility criteria

Age 12 to under 18 years old

Children under 18 years old at the time of enrollment.

Hair loss eposide

White patches that appear on both sides of the body, not limited to one area.

More than 50% affected.

Up to 50% of scalp hair loss, a doctor can help determine this request

Clinical Diagnosis

Your child has been formally diagnosed of alopecia areata by a doctor.

What happens if we enroll?

We understand your time matters. Here’s what to expect from start to finish.
1

Pre-screening

Complete a short form to see whether your child may be eligible based on basic criteria. No medical records needed at this stage.

2

Screening visit

If the pre-screen looks promising, you’ll meet with the study team in person. They’ll review your child’s history, examine the affected areas, and answer every question you have before any decisions are made.

3

Participation (if eligible)

Enrolled participants apply the investigational cream as directed and attend follow-up visits with the study team. Your child will receive close medical monitoring throughout, from vitiligo specialists.

4

Study Completion

The study team will walk you through what happens after the study ends, including next steps for your child’s ongoing care.

Why participate in a research study?

Clinical research plays a crucial role in providing children with access to new treatments and advancing medical knowledge for future generations. Our mission is to create new opportunities for children and families by advancing research and ensuring that they have access to innovative therapies that have the potential to transform lives.

Dr. Mercedes E. González

Pediatric Dermatology Specialist & Principal Investigator

What parents ask us most

Get straightforward explanations about how the research works, what it does, and how it supports your child’s health journey.

We are here to provide clarity.

Safety is the study’s top priority. The investigational medication has been studied in adults and is now being evaluated in adolescents. Your teen will be closely monitored with regular bloodwork, vital signs, and clinical assessments. An independent safety committee also reviews data continuously throughout the study.

Families are free to withdraw from the study at any time without consequence. Participation is entirely voluntary.

There is no cost to participate. Study medication, clinic visits, and all study-related lab work are provided at no charge. Participants may also receive compensation for time and travel — please speak with our team for details.

After completing the open-label extension, participants finish a 4-week follow-up visit. Our team will discuss ongoing care options at that time. Data collected will help advance treatment options for adolescents with alopecia areata.

Your teen may qualify for this study.

If your child has severe alopecia areata and is between the ages of 12 and 17, find out in less than 2 minutes whether they may be eligible to participate at no cost to your family.

Check Eligibility Now →

It only takes 20 seconds.

© 2026 PEDSKIN Research
All rights reserved

This is a research facility. Treatments are investigational.
Participation is voluntary.